![]() ![]() ![]() Medtronic conducted an extensive study assessing the impact of age and gender on osteoinductivity. ![]() Medtronic follows AATB guidelines in sourcing donors and works to maximize the use of donated tissue. Product processing consistency is confirmed via ongoing testing. Through a prospective randomized study of production allograft, we were able to validate that the D-Min process yields a consistently osteoinductive product. Controls in the D-Min process eliminate many of the variables that can affect the osteoinductivity of demineralized bone matrix. We use our proprietary D-Min process to demineralize the allograft tissue that goes into the different Grafton Bone Graft forms. Aseptic processing methods versus those employing ethylene oxide or terminal sterilization.Application of defatting agents such as ethanol.Acid concentration and soak time for demineralization.Allograft Tissue Aseptic Processing for More Consistencyīecause allograft tissue processing, including demineralization, has evolved over time and is performed by numerous processors, it is important to recognize that not all demineralization processes are alike. ![]()
0 Comments
Leave a Reply. |